Health
Covaxin: India’s first Coronavirus vaccine candidate approved for human trials. Here’s all you need to know – Times of India
India’s drug control authority, the Central Drugs Standard Control Organisation (CDSCO) has allowed BBIL to hold Phase I and II of human clinical trials, which are scheduled to start across India in July.
Covaxin is the first indigenous vaccine candidate to fight against the novel coronavirus, created and developed by BBIL. It is the first vaccine candidate to be approved for human trials.
According …
Continue Reading